Law360, New York (October 21, 2010, 6:10 PM ET) -- A federal judge has ordered Wyeth Inc. to turn over its previous settlement and licensing agreements over the oft-litigated drug Effexor XR, ruling that the documents could be relevant to Orchid Chemicals & Pharmaceuticals Ltd.'s defense in an ongoing patent suit over a generic version of the antidepressant.
Magistrate Judge Douglas E. Arpert of the U.S. District Court for the District of New Jersey granted the defendants' motion to compel Tuesday, overruling Wyeth's objections that the settlements were irrelevant to the current suit and that producing...
Wyeth Loses Bid To Keep Effexor Deals Under Wraps
To view the full article, take a free trial now.
